Pomona, California, June 29, 2006 - Amsino International, Inc., a leading medical device developer and manufacturer, has received 501K clearance from the FDA to market its AMSure^® disposable hypodermic syringes and needles.

These disposable syringes and needles are intended for hypodermic injection or aspiration of fluids. Syringes were designed with both luer slip and luer lock nozzles, and needles are intended to mate with both piston syringes and intravenous fluid administration sets. AMSure^® syringes will be available in multiple configurations, both with, and without, attached hypodermic needles.

"The development and US marketing clearance for our hypodermic syringes is an affirmation of Amsino's continuing commitment to providing the highest quality products and meeting customers requirements. This product is a great addition to our drug delivery system and access device portfolio," says Dr. Richard Lee, President and CEO.

Headquartered in Pomona, California, Amsino International, Inc. is a privately held medical device company with manufacturing and distribution facilities in the US and in Asia. Amsino products are mostly developed in the US, manufactured in China, and distributed in the United States and more than 30 other countries worldwide.

# # #

For additional information, please contact Ms. Margo Liang at at margo_liang@amsino.com.

BACK TO NEWS